U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
9594195941A Study to Assess the Transfer of Fospropofol and Its Active Metabolite, Propofol, to Breast Milk Following Administration of LUSEDRA to Lactating Women Undergoing a Needed ProcedureCompletedNo Results AvailableLactating WomenDrug: Lusedra|Drug: Propofolhttps://ClinicalTrials.gov/show/NCT01309984
9594295942DPBRN Longitudinal Study of Questionable Occlusal Caries LesionsCompletedNo Results AvailableDental Carieshttps://ClinicalTrials.gov/show/NCT01309971
9594395943DPBRN Development of a Patient Based Provider Intervention for Early Caries ManagementCompletedNo Results AvailableDental Carieshttps://ClinicalTrials.gov/show/NCT01309958
9594495944Efficacy and Safety of Flexibly Dosed BMS-820836 in the Treatment of Patients With Treatment Resistant Major DepressionCompletedNo Results AvailableDepressionDrug: Duloxetine|Drug: Placebo matching with BMS-820836|Drug: BMS-820836|Drug: Duloxetine|Drug: Placebo matching with Duloxetinehttps://ClinicalTrials.gov/show/NCT01309945
9594595945Safety Study of Pegylated Interferon Lambda Plus Single or 2 Direct Antiviral Agents With RibavirinCompletedNo Results AvailableHepatitis CBiological: Pegylated Interferon Lambda (pegIFNλ)|Drug: BMS-790052 (NS5A Inhibitor)|Drug: Ribavirin (RBV)|Drug: BMS-650032 (NS3 Protease Inhibitor)|Biological: Pegylated Interferon Alfa-2a (pegIFNα-2a)|Biological: Pegylated Interferon Lambda (pegIFNλ)|Drug: Ribavirin (RBV)|Biological: Pegylated Interferon Lambda (pegIFNλ)|Drug: Ribavirin (RBV)|Drug: BMS-790052 (NS5A Inhibitor)|Drug: BMS-650032 (NS3 Protease Inhibitor)|Drug: Placebo (PBO) for BMS-650032 (Placebo for NS3 Protease Inhibitor)|Drug: Placebo (PBO) for BMS-790052 (Placebo for NS5A Inhibitor)|Drug: Placebo for Ribavirin (RBV)|Drug: Placebo for Ribavirin (RBV)https://ClinicalTrials.gov/show/NCT01309932
9594695946Bleeding Patterns and Complications After Postpartum IUD Placement: a Pilot StudyCompletedHas ResultsPostpartum PeriodDevice: IUD|Other: Diaryhttps://ClinicalTrials.gov/show/NCT01309919
9594795947[Trial of device that is not approved or cleared by the U.S. FDA]WithheldNo Results Availablehttps://ClinicalTrials.gov/show/NCT01309906
9594895948A Study to Evaluate a New Silicone Hydrogel Contact LensCompletedHas ResultsMyopiaDevice: Investigational Lens|Device: Air Optix Aqua lenshttps://ClinicalTrials.gov/show/NCT01309893
9594995949Evaluation of a New Silicone Hydrogel Contact LensCompletedHas ResultsMyopiaDevice: Test lens|Device: Air Optix Aquahttps://ClinicalTrials.gov/show/NCT01309880
9595095950[Trial of device that is not approved or cleared by the U.S. FDA]WithheldNo Results Availablehttps://ClinicalTrials.gov/show/NCT01309867
9595195951Effects of Administration of Fostamatinib on Blood Concentrations of Pioglitazone in Healthy SubjectsCompletedNo Results AvailableRheumatoid Arthritis|Healthy Volunteers|Pharmacokinetics|Pioglitazone|Drug-drug Interaction|Amount of Pioglitazone in BloodDrug: fostamatinib|Drug: pioglitazonehttps://ClinicalTrials.gov/show/NCT01309854
9595295952Assessment of Efficacy and Safety in Patients With Non-cancer-related Pain and Opioid-induced ConstipationCompletedHas ResultsOpioid-Induced Constipation (OIC)Drug: NKTR-118|Drug: NKTR-118|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01309841
9595395953Long-Term Safety of Azilsartan Medoxomil and Chlorthalidone Compared to Olmesartan Medoxomil and Hydrochlorothiazide in Participants With Hypertension and Kidney DiseaseCompletedHas ResultsSafetyDrug: Azilsartan medoxomil and chlorthalidone|Drug: Olmesartan medoxomil and hydrochlorothiazidehttps://ClinicalTrials.gov/show/NCT01309828
9595495954Existential Issues in Elderly People With CancerCompletedNo Results AvailableCancerhttps://ClinicalTrials.gov/show/NCT01309815
9595595955A Two-Part Study of BOTOX® Therapy for Ischemic DigitsActive, not recruitingNo Results AvailableRaynaud's DiseaseDrug: onabotulinum toxin type-Ahttps://ClinicalTrials.gov/show/NCT01309802
9595695956A Phase 1 Study of Brentuximab Vedotin Given Sequentially and Combined With Multi-Agent Chemotherapy for CD30-Positive Mature T-Cell and NK-Cell NeoplasmsActive, not recruitingNo Results AvailableLymphoma, Large-Cell, Anaplastic|Lymphoma, NK-cell|Lymphoma, T-cellDrug: brentuximab vedotin|Drug: cyclophosphamide|Drug: brentuximab vedotin|Drug: prednisone|Drug: cyclophosphamide|Drug: doxorubicin|Drug: doxorubicin|Drug: prednisone|Drug: vincristinehttps://ClinicalTrials.gov/show/NCT01309789
9595795957Comparison of Tianeptine Versus Escitalopram Patients Major Depressive DisorderCompletedNo Results AvailableMajor Depressive DisorderDrug: Tianeptine|Drug: Escitalopramhttps://ClinicalTrials.gov/show/NCT01309776
9595895958Safety and Tolerability of AFFITOPE AD03CompletedNo Results AvailableAlzheimer's DiseaseBiological: AFFITOPE AD03|Biological: AFFITOPE AD03 + Alumhttps://ClinicalTrials.gov/show/NCT01309763
9595995959Small Bowel Transit Time in Clostridium Difficile ColitisTerminatedNo Results AvailableClostridium Difficile ColitisRadiation: Small Bowel Transit Studyhttps://ClinicalTrials.gov/show/NCT01309750
9596095960A One-Year Study To Evaluate The Efficacy And Safety Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque PsoriasisCompletedHas ResultsPsoriasisDrug: CP-690,550|Drug: CP-690,550|Drug: Placebo/CP-690,550|Drug: Placebo/CP-690,550https://ClinicalTrials.gov/show/NCT01309737
9596195961Hemodynamic Optimization By Non-Invasive Determination Of Cardiac Output In Critically Ill PatientsCompletedNo Results AvailableHypotensionOther: USCOM-guided fluid administrationhttps://ClinicalTrials.gov/show/NCT01309724
9596295962Magnetic Resonance Biomarkers in Neonatal EncephalopathyRecruitingNo Results AvailableNeonatal Encephalopathyhttps://ClinicalTrials.gov/show/NCT01309711
9596395963Drug Interaction of Vildagliptin (LAF237) With Voglibose in Japanese Patients With Type 2 DiabetesCompletedNo Results AvailableType 2 DiabetesDrug: Vildagliptin (LAF237)|Drug: Voglibose|Drug: Vildagliptin and Voglibosehttps://ClinicalTrials.gov/show/NCT01309698
9596495964Effect of Varenicline on Tobacco Addiction and on Abstinence-induced Cognitive ImpairmentWithdrawnNo Results AvailableDrug AddictionDrug: Vareniclinehttps://ClinicalTrials.gov/show/NCT01309685
9596595965S1014 Abiraterone Acetate in Treating Patients With Prostate Cancer Who Have Undergone Initial Hormone TherapyActive, not recruitingNo Results AvailableProstate CancerDrug: abiraterone acetate|Drug: degarelix|Drug: leuprolide acetate|Procedure: orchiectomyhttps://ClinicalTrials.gov/show/NCT01309672
9596695966Trial To Evaluate the Efficacy of Intravenous Iron in Older Adults With Unexplained AnemiaTerminatedHas ResultsAnemia|Unexplained AnemiaDrug: iron sucrose|Drug: iron sucrosehttps://ClinicalTrials.gov/show/NCT01309659
9596795967Immunogenicity and Safety of GlaxoSmithKline Biologicals' Infanrixâ„¢-IPV+Hib VaccineCompletedHas ResultsPoliomyelitis|Haemophilus Influenzae Type b Disease|Diphtheria|Pertussis|TetanusBiological: Infanrixâ„¢-IPV+Hib|Biological: Infanrixâ„¢ IPV|Biological: Hiberixâ„¢|Biological: Synflorixâ„¢|Biological: Rotarixâ„¢https://ClinicalTrials.gov/show/NCT01309646
9596895968Study Evaluating Two Loading Regimens of Sunitinib Alternating With Cisplatin and Gemcitabine as Induction Therapy for Locally Advanced Nasopharyngeal Carcinoma (NPC)RecruitingNo Results AvailableNasopharyngeal CarcinomaDrug: 12.5mg sunitinib with Cisplatin and Gemcitabine|Drug: 25mg Sunitinib alternating with Cisplatin and Gemcitabinehttps://ClinicalTrials.gov/show/NCT01309633
9596995969Zinc Supplementation in Type 2 DiabeticsCompletedNo Results AvailableDiabetes Mellitus, Non-Insulin-DependentDietary Supplement: Zinc gluconate|Dietary Supplement: Placebohttps://ClinicalTrials.gov/show/NCT01309620
9597095970Study of Preoperative Weekly Paclitaxel and Carboplatin With Lapatinib (Tykerb®) in Patients With ErbB2-Positive Stage I-III Breast CancerActive, not recruitingNo Results AvailableErbB2-Positive Stage I-III Breast CancerDrug: paclitaxel/carboplatin/lapatinibhttps://ClinicalTrials.gov/show/NCT01309607

* Görseller ve İçerik tekif hakkına sahip olabilir